Bank Central Asia Tbk vs Central Proteina Prima Tbk. — how do they compare? Bank Central Asia Tbk trades at Rp6,250 (market cap 774.97T, 20.9M 24h volume), while Central Proteina Prima Tbk. trades at Rp52 (market cap 3.16T, 31.26M 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 245.2× Central Proteina Prima Tbk.'s market cap, and Central Proteina Prima Tbk. is more actively traded (31.26M versus 20.9M). Which is the better fit depends on your goals.
| BBCA | CPRO | |
|---|---|---|
Market Cap | 774.97T | 3.16T |
Volume | 20.9M | 31.26M |
Lot | 209K | 312.62K |
Turnover | 131.41B | 1.62B |
Average Price | 6,287.44 | 51.89 |
Value | 131.41B | 1.62B |
Indicative Equilibrium Price | 6,350 | 53 |
Indicative Equilibrium Volume | 2.2M | 1.58M |
Trailing returns across standard periods
Latest headlines on both assets
PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.
Read more on BBCA →PT Central Proteinprima Tbk (The Company) was established on April 30, 1980 based on the Domestic Capital Investment Law No. 6 year 1968. Base on notarial deed no. 45 dated Dec 7, 1989 the company's share holders agreed offering 1.000.000 share to public, increase paid up capital and authorized capital. At 14 May 1990, the company's shares were treadeable in Jakarta Stock Exchange.Base on notarial deed no.7 dated 4 Oct 2004 of Fahiah Helmi, SH, the company was changed to private company. At Nov 5, 2004, base on JSX letter no S-1671/BEJ-PSR/11-2004 the company was delisted. And then at Sep 2004, the Company's ownership was changed to foreign investment. The Company’s articles of association has been amended several times, most recently by notarial deed No. 57 of Lies Herminingsih, S.H., dated Sep 30, 2006, concerning change of director's job description.
Read more on CPRO →